Generian Pharmaceuticals
Pittsburgh
About Generian Pharmaceuticals
Generian team has developed an innovative approach to uncover first-in-class, gain-of-function drugs that activate key cellular networks linked to quality control and metabolism. Activation of these validated networks represents a unique approach with applicability across a broad range of chronic diseases. Led by top researchers in the fields of aging, small molecule drug development, and E3 ubiquitin ligase biology, Generian's platform will transform how we treat a wide array of both rare and common conditions using small molecules to reset and restore cellular homeostasis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.0M
- Last round: Series Unknown (Oct 2019)
- Website: generian.com
- Phone: 412-770-1621
Industries & Categories
Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/generian-pharmaceuticals-116234 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.